Main Article Content

Abstract

Wilson’s disease is an autosomal receives disorder which is characterized by degenerative changes in brain, liver disease and kayser Fleisher (KF) rings in the cornea. It is due to a defect of P-type ATP ase and probably required for normal extrusion of copper from cells. Wilson’s disease which is an inborn error of copper metabolism can present as hepatic, neurological or psychiatric disease, older adult may present with this disease. In this review we have mainly discussed different pharmacological treatments and also non-pharmacological agents which are help- ful in management of Wilson disease.

Keywords

ATP 7 B gene copper hepatolenticular degeneration Wilson disease

Article Details

How to Cite
DE, A., & Bala, N. N. (2017). Current treatment of Wilson disease. International Journal of Research in Phytochemistry and Pharmacology, 7(2), 44-49. Retrieved from https://scienztech.org/index.php/ijrpp/article/view/910